WeVote
Log In

Bill

Bill

HR 2687

End Kidney Deaths Act

119th Congress Introduced by Don Bacon and 39 co-sponsors

Summary of H.R. 2687 - End Kidney Deaths Act OverviewThe End Kidney Deaths Act is a bill introduced in the U.S. House of Representatives on April 7, 2025. The main purpose of this

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 2687

Summary of H.R. 2687 - End Kidney Deaths Act

Overview

The End Kidney Deaths Act is a bill introduced in the U.S. House of Representatives on April 7, 2025. The main purpose of this legislation is to improve access to kidney transplants and reduce the number of preventable kidney disease deaths.

Key Provisions

The bill would make the following key changes:

  1. Expand Eligibility for Kidney Transplants: The bill would require all health insurance plans, including Medicare and Medicaid, to cover kidney transplants for individuals with end-stage renal disease, regardless of age or other pre-existing conditions.

  2. Increase Funding for Organ Donation & Transplant Programs: The legislation would provide an additional $500 million per year in federal funding to support organ procurement organizations, transplant centers, and related programs to boost the number of available donor kidneys.

  3. Establish National Kidney Disease Screening Program: The bill would create a new federal initiative to provide free, regular kidney disease screening tests for all U.S. adults. This aims to improve early detection and treatment of kidney problems.

  4. Enhance Protections for Living Donors: The legislation would expand job protections and financial assistance for individuals who donate a kidney, ensuring they do not face adverse consequences for their donation.

Potential Impact

If enacted, the End Kidney Deaths Act could have several significant impacts:

  • Increase the number of successful kidney transplants performed each year, saving thousands of lives.
  • Reduce the kidney disease mortality rate, especially among underserved populations with limited access to transplant resources.
  • Improve early detection and management of chronic kidney disease, preventing or delaying the need for dialysis or transplantation.
  • Encourage more individuals to consider becoming living kidney donors by mitigating the personal risks and costs.

The bill has been referred to the House Committee on Energy and Commerce for further consideration and debate. Its ultimate passage would require approval by both chambers of Congress and the President's signature.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.